315 related articles for article (PubMed ID: 33956455)
21. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.
Dimitrijevic D; Shaw AJ; Florence AT
J Pharm Pharmacol; 2000 Feb; 52(2):157-62. PubMed ID: 10714945
[TBL] [Abstract][Full Text] [Related]
22. Involvement of the H+/organic cation antiporter in nicotine transport in rat liver.
Tega Y; Akanuma S; Kubo Y; Hosoya K
Drug Metab Dispos; 2015 Jan; 43(1):89-92. PubMed ID: 25352656
[TBL] [Abstract][Full Text] [Related]
23. Interaction of pharmaceutical excipients with organic cation transporters.
Soodvilai S; Soodvilai S; Chatsudthipong V; Ngawhirunpat T; Rojanarata T; Opanasopit P
Int J Pharm; 2017 Mar; 520(1-2):14-20. PubMed ID: 28131852
[TBL] [Abstract][Full Text] [Related]
24. Role of organic cation transporters in drug-drug interaction.
Koepsell H
Expert Opin Drug Metab Toxicol; 2015; 11(10):1619-33. PubMed ID: 26206523
[TBL] [Abstract][Full Text] [Related]
25. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines.
Lo YL
J Control Release; 2003 Jun; 90(1):37-48. PubMed ID: 12767705
[TBL] [Abstract][Full Text] [Related]
26. Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol.
Te Brake LH; van den Heuvel JJ; Buaben AO; van Crevel R; Bilos A; Russel FG; Aarnoutse RE; Koenderink JB
Antimicrob Agents Chemother; 2016 Dec; 60(12):7105-7114. PubMed ID: 27645247
[TBL] [Abstract][Full Text] [Related]
27. Involvement of carnitine/organic cation transporter OCTN1/SLC22A4 in gastrointestinal absorption of metformin.
Nakamichi N; Shima H; Asano S; Ishimoto T; Sugiura T; Matsubara K; Kusuhara H; Sugiyama Y; Sai Y; Miyamoto K; Tsuji A; Kato Y
J Pharm Sci; 2013 Sep; 102(9):3407-17. PubMed ID: 23666872
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
[TBL] [Abstract][Full Text] [Related]
29. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y
J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731
[TBL] [Abstract][Full Text] [Related]
30. Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3).
Liang X; Chien HC; Yee SW; Giacomini MM; Chen EC; Piao M; Hao J; Twelves J; Lepist EI; Ray AS; Giacomini KM
Mol Pharm; 2015 Dec; 12(12):4301-10. PubMed ID: 26528626
[TBL] [Abstract][Full Text] [Related]
31. Effects of tetraalkylammonium compounds with different affinities for organic cation transporters on the pharmacokinetics of metformin.
Choi MK; Jin QR; Jin HE; Shim CK; Cho DY; Shin JG; Song IS
Biopharm Drug Dispos; 2007 Dec; 28(9):501-10. PubMed ID: 17876861
[TBL] [Abstract][Full Text] [Related]
32. Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters.
Martel F; Gründemann D; Calhau C; Schömig E
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):40-9. PubMed ID: 11191835
[TBL] [Abstract][Full Text] [Related]
33. Multiple Transport Mechanisms Involved in the Intestinal Absorption of Metformin: Impact on the Nonlinear Absorption Kinetics.
Shirasaka Y; Seki M; Hatakeyama M; Kurokawa Y; Uchiyama H; Takemura M; Yasugi Y; Kishimoto H; Tamai I; Wang J; Inoue K
J Pharm Sci; 2022 May; 111(5):1531-1541. PubMed ID: 35090865
[TBL] [Abstract][Full Text] [Related]
34. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
[TBL] [Abstract][Full Text] [Related]
35. Effect of Cimetidine on Metformin Pharmacokinetics and Endogenous Metabolite Levels in Rats.
Ailabouni AS; Mettu VS; Thakur A; Singh DK; Prasad B
Drug Metab Dispos; 2024 Jan; 52(2):86-94. PubMed ID: 38049999
[TBL] [Abstract][Full Text] [Related]
36. Co-administration of nuciferine reduces the concentration of metformin in liver via differential inhibition of hepatic drug transporter OCT1 and MATE1.
Li L; Lei H; Wang W; Du W; Yuan J; Tu M; Zhou H; Zeng S; Jiang H
Biopharm Drug Dispos; 2018 Nov; 39(9):411-419. PubMed ID: 30294927
[TBL] [Abstract][Full Text] [Related]
37. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo.
Cornaire G; Woodley J; Hermann P; Cloarec A; Arellano C; Houin G
Int J Pharm; 2004 Jun; 278(1):119-31. PubMed ID: 15158955
[TBL] [Abstract][Full Text] [Related]
38. Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter.
Sawangrat K; Yamashita S; Tanaka A; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
J Pharm Sci; 2019 Mar; 108(3):1315-1325. PubMed ID: 30389568
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms underlying saturable intestinal absorption of metformin.
Proctor WR; Bourdet DL; Thakker DR
Drug Metab Dispos; 2008 Aug; 36(8):1650-8. PubMed ID: 18458049
[TBL] [Abstract][Full Text] [Related]
40. Organic Cation Transporters in Human Physiology, Pharmacology, and Toxicology.
Samodelov SL; Kullak-Ublick GA; Gai Z; Visentin M
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
